Back to DirectoryParenteral Nutrition
Parenteral Nutrition

Clinimix E 5/15 sulfite free w/ elect in dextrose 15% w/ calcium

Osmolarity: ≈ 1,505 mOsm/LTonicity: HypertonicpH: 5.0 – 6.5 Central Line Required

Clinical Indications

Balanced high-protein, moderate-glucose TPN. Provides >1,000 kcal/L with high nitrogen content — suited for catabolic ICU patients requiring both protein repletion and energy.

Dosing & Administration Rate

Glucose:nitrogen ratio approximately 150 g dextrose per 7.7 g N. Monitor glucose, electrolytes, and weekly LFTs.

Warnings & Precautions

Central access required. Hyperglycaemia common — insulin protocol. High nitrogen requires monitoring of renal function and BUN.

Contraindications

Known hypersensitivity to amino acids. Severe liver disease or hepatic coma. Severe renal impairment (without dialysis). Abnormalities of amino acid metabolism.

Pharmacology & Safety Profile

Mechanism of Action

Provides a source of biologically utilizable essential and non-essential amino acids for protein synthesis, and dextrose as a source of calories.

Adverse Reactions

Phlebitis, fluid overload, hyperglycemia, hyperosmolar syndrome, electrolyte imbalances, metabolic acidosis, liver enzyme elevations.

Compatibility Notes

Standard TPN admixture additions.

Electrolyte & Composition Profile

ComponentAmount / Concentration
Amino Acids50 g/L (5%)
Dextrose (Anhydrous)150 mg/mL (15%)
Electrolytes (Na, K, Ca, Mg, Phosphate)Standard Clinimix E panel
Nitrogen Content≈ 7.7 g/L
Caloric Density≈ 1,010 kcal/L
Nitrogen Content7.7 g N/L

Clinical Parameters

RouteIntravenous (central venous access)
Fluid CategoryParenteral Nutrition
Required MonitoringVital signs, fluid intake/output, baseline electrolytes
Administration SetupCentral venous catheter required.
Pregnancy SafetyCategory C (FDA). Animal reproduction studies have not been conducted. Should be given to a pregnant woman only if clearly needed.
StorageRoom temperature. Protect from freezing.
Prescription Status Rx Only

Clinical Disclaimer: Data compiled from FDA DailyMed, Baxter/Fresenius prescribing information, and USP monographs. Always verify against the physical product label, your institution's IV protocols, and current pharmacist guidance before administration.